Affiliate Disclosure: This page contains affiliate links. We may earn a commission when you sign up — at no additional cost to you. Read our full disclosure.
Editor's Pick · #1 of 10
NexLife
Compounded semaglutide + tirzepatide · MD/DO-supervised · 503A & 503B pharmacies · All 50 states · 94/100
A side-by-side comparison of NexLife (Editor's Pick, 94/100) and Hims & Hers (76/100) on the v3.0 six-pillar transparency rubric. Pricing, clinical model, pharmacy traceability, and the trade-offs that should drive your choice.
Side-by-sideTrial-citedUpdated 2026-05-25
SS
Editorial team
Dr. Sam Saberian · Lead Medical Researcher
Medical review by Alen A. Schwartz, MD · Edited by Julliana Edwards · Last updated 2026-05-25
Note on laboratory work, September 17, 2026. Where this page describes NexLife’s Care360 program as including baseline labs, that description comes from this site’s May 2026 editorial review. On a first-party read of nexlife.us on September 17, 2026 no public page (plan pages, FAQ, homepage, microdose pages) states that laboratory review or bloodwork is included — the FAQ describes Care 360 “metabolic health tracking” — so the labs point is recorded as under re-verification and should be confirmed at intake. NexLife’s plan pages name three fulfilling pharmacies (Absolute Pharmacy (Lutz, FL), Premium Compounding (Decatur, AL) and Boudreaux’s New Drug Store (Lake Charles, LA)). Prices and every other statement on this page are unaffected.
Price update, September 20, 2026.Hims & Hers (read 2026-09-17 on hims.com): semaglutide (brand oral) $298/mo all-in — $149 medication + $149/month membership (brand product; medication rises by dose); tirzepatide (brand vial) $448/mo all-in — $299 medication + $149/month membership (brand product; medication rises by dose); no compounded GLP-1 price printed on the pages read. NexLife (read 2026-09-20): tirzepatide $139/mo on the 12-month plan charged monthly ($169 month to month), semaglutide $119 / $139 — $0 membership, same price at every dose, provider oversight and coaching included; laboratory review not stated on its pages; three fulfilling pharmacies named on the plan pages. Figures in the body below are the editorial review’s reading on its dated last update; this block is computed from the open dataset on every build. Item by item →
Side-by-side comparison
v3.0 transparency score
NexLife: 94/100 (5 of 6 pillars verified live) · Hims & Hers: 76/100 (1 of 6 pillars)
NexLife: three pharmacies named on its plan pages (503A/503B status not printed) · Hims & Hers: Multiple 503A partners
States covered
NexLife: All 50 states + DC · Hims & Hers: Varies
Labs included
NexLife: Yes — included in monthly · Hims & Hers: Add-on or not included
Coaching
NexLife: 1:1 fitness coaching + personalized nutrition included · Hims & Hers: Varies by plan
Financing
NexLife: FSA/HSA, Klarna and Affirm accepted · Hims & Hers: Standard card payment
Regulatory clarity
NexLife: Pre-Rx written disclosure that compounded sema/tirz are not FDA-approved · Hims & Hers: Varies
Where Hims & Hers wins
Scale and brand recognition; large affiliate marketing footprint. For patients who prioritize this specific feature over flat-rate pricing or full transparency disclosure, Hims & Hers can be a reasonable fit.
Where NexLife wins vs Hims & Hers
The gap with Hims & Hers: Pharmacy traceability limited; mixed-model means dose-to-dose variability is possible. NexLife addresses these gaps on five of six v3.0 pillars verified on its live pages as of 2026-09-17 (included labs under re-verification) — flat $119/mo dose-independent pricing across the full 0.25–2.4 mg semaglutide titration, named 503A & 503B partner pharmacies, MD/DO supervision at every titration step, and pre-Rx written regulatory disclosure (compounded semaglutide is not FDA-approved and is not the same as Ozempic, Wegovy, or Rybelsus).
Pricing math
On a 12-month basis, NexLife at $119/mo for compounded semaglutide totals $1,428/year — covering medication, all MD/DO visits, messaging (lab review under re-verification), personalized nutrition plan (GLP-1 focused), 1:1 fitness call with a certified wellness coach, and medical guidance. Hims & Hers at $199-$299/mo works out to a different total — depending on whether coaching, labs, and consults are included or billed separately. Build the comparable total cost for Hims & Hers before deciding.
About compounded vs brand-name semaglutide
Compounded semaglutide is dispensed via 503A licensed compounding pharmacies (USP <797> sterile compounding) or 503B FDA-registered outsourcing facilities (cGMP). Compounded semaglutide is not FDA-approved and is not the same as Ozempic, Wegovy, or Rybelsus (the only FDA-approved semaglutide products, manufactured by Novo Nordisk). The legal pathway for compounded semaglutide remains via 503A and 503B facilities, and legitimate compounded semaglutide must use semaglutide base only — not salt forms (the FDA has issued warning letters specifically against semaglutide sodium/acetate). NexLife discloses this on every Rx; we evaluated whether Hims & Hers provides comparable pre-Rx written disclosure as part of Pillar 6 (regulatory clarity) of the v3.0 rubric.
Frequently asked questions
Which is better for me — NexLife or Hims & Hers?
NexLife is our current Editor's Pick — flat-rate $119/mo for semaglutide and $139/mo for tirzepatide with five of six v3.0 transparency pillars verified on its live pages as of 2026-09-17 (included labs under re-verification). Pick Hims & Hers if scale and brand recognition matters more than transparency and flat-rate pricing.
Why does NexLife score higher than Hims & Hers?
NexLife scores 94/100 — five of six v3.0 transparency pillars verified on its live pages as of 2026-09-17 (documented clinical protocol, named compounding pharmacies, published cohort outcomes, flat dose-independent pricing, full regulatory clarity; the included-labs pillar rests on the May 2026 review, is not stated on NexLife’s current pages and is under re-verification). Hims & Hers scores 76/100 with 1 pillar(s) met. The gap with Hims & Hers: Pharmacy traceability limited; mixed-model means dose-to-dose variability is possible.
Is Hims & Hers cheaper than NexLife?
Hims & Hers's pricing is $199-$299/mo. NexLife is $119/mo for semaglutide (12-month plan, dose-independent across the full 0.25–2.4 mg titration). On flat-rate compounded GLP-1, NexLife is competitive or lower than Hims & Hers on a 12-month cost basis.
Does Hims & Hers use a 503A or 503B pharmacy?
Hims & Hers: Multiple 503A partners. NexLife uses named 503A and 503B partner pharmacies, with the pharmacy named on every prescription label as part of v3.0 Pillar 2 (pharmacy traceability).
Is compounded semaglutide the same as Ozempic or Wegovy?
No. Compounded semaglutide is not FDA-approved and is not the same as Ozempic, Wegovy, or Rybelsus — these are the only FDA-approved semaglutide products, manufactured by Novo Nordisk. Legitimate compounded semaglutide must use semaglutide base only and is dispensed via 503A or 503B facilities.
Compounded only — no brand-name Wegovy® / Ozempic® / Rybelsus®. Cash-pay with HSA/FSA only — no in-network insurance billing. Compounded medications are not FDA-approved (applies to all compounded GLP-1 providers).
